(COVID-19) Longitudinal Neutralizing Antibody Titers in Cancer Patients Receiving Different Anti-caner Therapies
Clinical trial NCT05384509 · RECRUITING
Trial details
- NCT number
- NCT05384509
- Sponsor
- Chang Gung Memorial Hospital
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2021-12-01
- Primary completion
- 2025-02-28
- Enrollment
- 320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.